We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+13.64%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$744B
AUM Growth
+$61.8B
Cap. Flow
-$20.1B
Cap. Flow %
-2.7%
Top 10 Hldgs %
31.13%
Holding
2,974
New
92
Increased
1,834
Reduced
805
Closed
67

Top Buys

Rank Stock Value
1
DG icon
Dollar General
DG
+$1.37B
2
INTC icon
Intel
INTC
+$1.28B
3
SCHW
Charles Schwab
SCHW
+$1B
4
NKE icon
Nike
NKE
+$859M
5
UBER icon
Uber
UBER
+$825M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.67B
2
AMZN icon
Amazon
AMZN
+$2.15B
3
NVDA icon
NVIDIA
NVDA
+$1.64B
4
HUM icon
Humana
HUM
+$1.57B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.33B

Sector Composition

Rank Sector Weight
1 Technology 31.09%
2 Healthcare 15.81%
3 Financials 11.13%
4 Consumer Discretionary 10.82%
5 Communication Services 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DM
2576
DELISTED
Desktop Metal, Inc.
DM
$180K ﹤0.01%
23,841
+6,420
+37% +$58.1K
IAS
2577
DELISTED
Integral Ad Science
IAS
$178K ﹤0.01%
12,337
+1,550
+14% +$20.7K
PVBC
2578
DELISTED
Provident Bancorp
PVBC
$178K ﹤0.01%
17,600
DX
2579
Dynex Capital
DX
$3.23B
$177K ﹤0.01%
14,125
+1,919
+16% +$22K
HROW icon
2580
Harrow
HROW
$1.46B
$176K ﹤0.01%
15,639
+1,523
+11% +$18K
PTLO icon
2581
Portillo's
PTLO
$365M
$176K ﹤0.01%
11,046
+530
+5% +$8.19K
SYRS
2582
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$176K ﹤0.01%
22,550
CDZI icon
2583
Cadiz
CDZI
$295M
$175K ﹤0.01%
62,211
+1,186
+2% +$3.58K
GEVO icon
2584
Gevo
GEVO
$401M
$174K ﹤0.01%
149,479
+25,900
+21% +$29.6K
MRSN
2585
DELISTED
Mersana Therapeutics
MRSN
$174K ﹤0.01%
2,999
-486
-14% -$19.6K
PRM icon
2586
Perimeter Solutions
PRM
$5.53B
$174K ﹤0.01%
37,738
+2,815
+8% +$10.8K
DRVN icon
2587
Driven Brands
DRVN
$2.12B
$173K ﹤0.01%
12,066
+1,460
+14% +$18.2K
QNST icon
2588
QuinStreet
QNST
$1.19B
$173K ﹤0.01%
13,494
+1,585
+13% +$17.9K
RPAY icon
2589
Repay Holdings
RPAY
$317M
$173K ﹤0.01%
20,250
+952
+5% +$6.71K
MERC icon
2590
Mercer International
MERC
$33.8M
$172K ﹤0.01%
18,123
GNK icon
2591
Genco Shipping & Trading
GNK
$1.13B
$171K ﹤0.01%
+10,276
New +$149K
GRTS
2592
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$171K ﹤0.01%
83,489
+2,954
+4% +$5.39K
ARIS
2593
DELISTED
Aris Water Solutions
ARIS
$170K ﹤0.01%
20,205
LUNA
2594
DELISTED
Luna Innovations Incorporated
LUNA
$170K ﹤0.01%
25,460
+398
+2% +$2.46K
AVIR icon
2595
Atea Pharmaceuticals
AVIR
$406M
$169K ﹤0.01%
55,169
+12,927
+31% +$39.1K
ARKO icon
2596
ARKO Corp
ARKO
$505M
$167K ﹤0.01%
20,124
+1,783
+10% +$13.7K
KLG
2597
DELISTED
WK Kellogg Co
KLG
$166K ﹤0.01%
+12,629
New +$142K
PAHC icon
2598
Phibro Animal Health
PAHC
$1.38B
$166K ﹤0.01%
14,330
+298
+2% +$3.36K
WHG icon
2599
Westwood Holdings Group
WHG
$184M
$166K ﹤0.01%
+13,200
New +$140K
IMAX icon
2600
IMAX
IMAX
$2.92B
$165K ﹤0.01%
10,929
+806
+8% +$13.8K

Similar funds

T. Rowe Price Associates's Q4 2023 Portfolio in Review

As of Q4 2023, T. Rowe Price Associates held 2,974 positions worth $744B, up 9.1% from $682B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

T. Rowe Price Associates's Q4 2023 filing shows 92 new, 1,834 increased, 805 reduced and 67 closed positions. Its largest new stake was Canadian Natural Resources: 6,473,658 shares worth $212M. The largest sale was Microsoft, an estimated $2.67B.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q4 2023 buy was Canadian Natural Resources: 6,473,658 shares worth $212M.
  • T. Rowe Price Associates added most to Dollar General in Q4 2023, an estimated $1.37B increase.
  • T. Rowe Price Associates's biggest Q4 2023 reduction was Microsoft, cutting an estimated $2.67B.
  • T. Rowe Price Associates fully exited Activision Blizzard in Q4 2023, selling an estimated $293M.
  • T. Rowe Price Associates's ten largest holdings make up 31% of its $744B portfolio in Q4 2023.
  • T. Rowe Price Associates opened 92 new positions and closed 67 in Q4 2023.
  • T. Rowe Price Associates's portfolio value rose 9.1% quarter-over-quarter to $744B.

Based on T. Rowe Price Associates's 13F filing for Q4 2023, filed 14 Feb 2024.